Last update 01 Nov 2024

FOLR1 x FOLR2 x Tubulin

Basic Info

Related Targets
FOLR1FOLR2Tubulin

Related

1
Drugs associated with FOLR1 x FOLR2 x Tubulin
Vintafolide
Target
FOLR1 x FOLR2 x Tubulin
Mechanism
FOLR1 agonists [+2]
Active Org.
Merck Sharp & Dohme Corp.Merck Sharp & Dohme Corp. [+1]
Originator Org.
Novartis Pharma AG
Active Indication
Non-Small Cell Lung Cancer
Inactive Indication
Adenocarcinoma of Lung [+7]
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
10
Clinical Trials associated with FOLR1 x FOLR2 x Tubulin
NCT01953536 / WithdrawnPhase 2
A Phase IIa Open Label, Randomized Clinical Trial to Study the Safety and Efficacy of Vintafolide and the Combination of Vintafolide and Paclitaxel Compared to Paclitaxel in Subjects With Advanced Triple Negative Breast Cancer Using Etarfolatide (EC20) Subject Selection
100 Clinical Results associated with FOLR1 x FOLR2 x Tubulin
Login to view more data
100 Translational Medicine associated with FOLR1 x FOLR2 x Tubulin
Login to view more data
0 Patents (Medical) associated with FOLR1 x FOLR2 x Tubulin
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free